Status:
RECRUITING
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Lead Sponsor:
Center for Eye Research Australia
Conditions:
Age Related Macular Degeneration
Geographic Atrophy
Eligibility:
All Genders
18+ years
Brief Summary
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss worldwide, and nearly two million Australians have some signs of AMD. This proposed project is a prospective, ob...
Eligibility Criteria
Inclusion
- 18 years of age or older; and
- either AMD (defined as having at least a medium druse \>63 um), or having eyes with normal ageing changes (including small drusen ≤63 um) or no abnormalities as control participants
Exclusion
- ocular or systemic conditions other than AMD that could compromise retinal assessment or assessment of AMD and its progression; or
- any participant with any mental or physical impairment that prevents them from signing an informed consent form or participating in this study.
Key Trial Info
Start Date :
February 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2040
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04739319
Start Date
February 2 2021
End Date
November 1 2040
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Eye Research Australia
East Melbourne, Victoria, Australia, 3002